Sonic Healthcare Ltd
ASX:SHL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
24
32.36
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SHL stock under the Base Case scenario is 31.37 AUD. Compared to the current market price of 27.97 AUD, Sonic Healthcare Ltd is Undervalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Sonic Healthcare Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SHL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Sonic Healthcare Ltd. is a global leader in the provision of laboratory medicine and diagnostic services, successfully weaving its way into the fabric of healthcare across diverse markets. Founded in Australia in 1987, the company has expanded its operations internationally, boasting a network that spans Europe, North America, Asia, and New Zealand. Sonic's core business involves pathology and radiology services, which cater to hospitals, general practices, and patients, ensuring accurate and timely diagnoses. With a keen focus on innovation, Sonic integrates advanced technology and artificial intelligence into its processes, enhancing the quality and efficiency of its services, while also a...
Sonic Healthcare Ltd. is a global leader in the provision of laboratory medicine and diagnostic services, successfully weaving its way into the fabric of healthcare across diverse markets. Founded in Australia in 1987, the company has expanded its operations internationally, boasting a network that spans Europe, North America, Asia, and New Zealand. Sonic's core business involves pathology and radiology services, which cater to hospitals, general practices, and patients, ensuring accurate and timely diagnoses. With a keen focus on innovation, Sonic integrates advanced technology and artificial intelligence into its processes, enhancing the quality and efficiency of its services, while also adhering to stringent regulatory standards. This commitment to excellence has positioned Sonic as a trusted partner in the healthcare ecosystem, crucial for both patient outcomes and the smooth functioning of healthcare systems.
Investors looking at Sonic Healthcare will appreciate the company's resilient growth trajectory and prudent operational strategy. The company's revenue stream is underpinned by long-term contracts with healthcare providers and government entities, providing a stable and predictable cash flow. Sonic has demonstrated a history of profitability, underpinned by strategic acquisitions that bolster its market share and capabilities. Furthermore, the company's significant investment in research and development not only drives technological advancements but also aligns with evolving healthcare needs. As the global demand for diagnostic services continues to rise, driven by factors like an aging population and increased emphasis on preventive care, Sonic Healthcare presents a compelling investment opportunity for those seeking exposure to the robust and essential healthcare sector.
Sonic Healthcare Ltd. is a global healthcare company primarily focused on laboratory medicine, diagnostic imaging, and related services. Its core business segments can be categorized as follows:
-
Laboratory Medicine:
- This is Sonic Healthcare's largest segment, providing a range of pathology services. The focus is on offering medical diagnostic testing, including blood tests, tissue analysis, and various other laboratory services.
- The company operates numerous laboratories that utilize advanced technologies and methodologies to deliver accurate and timely results.
-
Diagnostic Imaging:
- This segment encompasses medical imaging services, including radiology, ultrasound, CT scans, MRI, and other imaging modalities.
- Sonic Healthcare provides these diagnostic services through outpatient facilities and hospital partnerships, aiming to deliver high-quality imaging to assist in patient diagnosis and treatment.
-
Primary Care and Specialist Services:
- Sonic Healthcare operates general practice services and specialty clinics that may include various medical fields such as dermatology, radiology, and more.
- This segment provides integrated healthcare solutions and may also include minor procedures and specialist consultations.
-
Veterinary Services:
- While primarily focused on human healthcare, Sonic Healthcare also has a segment dedicated to veterinary pathology and lab services. This includes diagnostic services for animal health.
- This segment reinforces Sonic's broad expertise in laboratory processes and its operational capabilities in the healthcare sector.
-
Healthcare Information Technology:
- Sonic Healthcare invests in digital health solutions and laboratory information systems. This segment focuses on improving operational efficiency, data management, and enhancing the customer experience through technological innovation.
These segments enable Sonic Healthcare to provide a comprehensive suite of services aimed at improving patient outcomes and streamlining healthcare delivery systems. The company operates in various countries, establishing a global footprint while adapting to local market needs and regulatory environments.
Sonic Healthcare Ltd has established several unique competitive advantages over its rivals in the healthcare and medical diagnostics sector. Here are some key aspects:
-
Diverse Service Offerings: Sonic Healthcare provides a wide range of services, including pathology, radiology, and clinical healthcare. This diversity allows them to cater to various customer needs and create synergistic opportunities, making them a one-stop-shop for healthcare providers.
-
Strong Brand Reputation: With a long-standing history and consistent performance, Sonic has built a strong brand that is trusted by healthcare professionals and patients. Brand recognition can facilitate partnerships and client retention.
-
Scale and Infrastructure: Sonic Healthcare operates across multiple countries and has a significant scale advantage, leading to efficiencies in operations, procurement, and resource allocation. This scale can help reduce costs and improve profitability, which smaller rivals may struggle to match.
-
Investment in Technology and Innovation: The company emphasizes technology and innovation in its testing and diagnostic processes. By leveraging advanced technologies, Sonic can enhance the accuracy, speed, and efficiency of its services, providing a competitive edge.
-
Quality Control and Accreditations: Sonic Healthcare prioritizes high standards of quality and safety, which can lead to higher customer satisfaction and trust. The company often holds numerous certifications and accreditations that reassure clients about their commitment to quality.
-
Decentralized Management: Sonic operates through a decentralized model, giving its various business units the autonomy to cater to local markets effectively. This flexibility allows them to respond swiftly to market changes, customer requirements, and regional regulations.
-
Strong Financial Position: A robust financial foundation allows Sonic to invest in growth opportunities, technologies, and acquisitions that can enhance their market position further, offering an advantage over competitors that may face financial constraints.
-
Strategic Acquisitions: Sonic has a history of successful acquisitions that enhance its market share and service breadth. This strategy enables the company to enter new markets quickly and consolidate its position against competitors.
-
Experienced Management Team: The leadership at Sonic Healthcare is seasoned and skilled, driving strategic vision and operational excellence. An experienced team can make informed decisions that propel the company forward amidst competitive pressures.
-
Focus on Customer Relationships: Sonic Healthcare builds strong relationships with healthcare providers, focusing on customer service and support. This commitment fosters loyalty and encourages consistent business from their partners.
These competitive advantages combined create a strong market position for Sonic Healthcare Ltd, allowing it to outperform many of its rivals in the medical diagnostics industry.
Sonic Healthcare Ltd, as a prominent global healthcare company specializing in diagnostic services and pathology, faces several risks and challenges in the near future:
-
Regulatory Changes: The healthcare industry is subject to stringent regulations, which can vary significantly across different regions. Changes in healthcare policies, reimbursement rates, or compliance standards could impact Sonic’s operations.
-
Market Competition: The diagnostics and pathology sectors are highly competitive. Sonic faces competition from both established players and new market entrants, which could impact market share and pricing pressures.
-
Technological Advances: Rapid advancements in technology, such as AI and genomics, may require substantial investments in innovation. Failing to keep pace with technological developments could lead to obsolescence.
-
Economic Factors: Economic downturns can affect healthcare spending. Reduced demand for elective procedures or diagnostic tests during recessions can directly impact revenue.
-
Global Supply Chain Disruptions: The COVID-19 pandemic highlighted vulnerabilities in global supply chains. Ongoing geopolitical tensions or pandemics can lead to disruptions in the supply of essential materials and equipment.
-
Labor Market Dynamics: The healthcare sector is facing workforce shortages and increasing labor costs. Attracting and retaining skilled professionals is crucial for maintaining service quality and operational efficiency.
-
Data Security and Privacy: As a provider of diagnostic services, Sonic handles vast amounts of sensitive patient information. Cybersecurity threats and data privacy regulations (like GDPR) pose significant risks, as breaches can lead to financial penalties and reputational damage.
-
Currency Fluctuations: Being a global company, Sonic is exposed to currency exchange risks, which can affect profitability when revenues are generated in various currencies.
-
Changing Consumer Behaviors: There is a growing trend towards personalized medicine and patient-centered care. Adapting to changing patient preferences and expectations is crucial for long-term success.
-
Healthcare Trends: Changes in public health trends, such as increased demand for at-home testing or preventative healthcare, require Sonic to pivot its strategies and service offerings.
By addressing these risks proactively, Sonic Healthcare can enhance its resilience and sustain its competitive advantage in the dynamic healthcare industry.
Revenue & Expenses Breakdown
Sonic Healthcare Ltd
Balance Sheet Decomposition
Sonic Healthcare Ltd
Current Assets | 2.4B |
Cash & Short-Term Investments | 645m |
Receivables | 1.4B |
Other Current Assets | 345.8m |
Non-Current Assets | 12.5B |
Long-Term Investments | 198.3m |
PP&E | 3.1B |
Intangibles | 9.1B |
Other Non-Current Assets | 97m |
Current Liabilities | 2.3B |
Accounts Payable | 1.2B |
Other Current Liabilities | 1.1B |
Non-Current Liabilities | 4.6B |
Long-Term Debt | 3.9B |
Other Non-Current Liabilities | 732.3m |
Earnings Waterfall
Sonic Healthcare Ltd
Revenue
|
9B
AUD
|
Cost of Revenue
|
-1.5B
AUD
|
Gross Profit
|
7.5B
AUD
|
Operating Expenses
|
-6.7B
AUD
|
Operating Income
|
849.7m
AUD
|
Other Expenses
|
-338.6m
AUD
|
Net Income
|
511.1m
AUD
|
Free Cash Flow Analysis
Sonic Healthcare Ltd
AUD | |
Free Cash Flow | AUD |
SHL Profitability Score
Profitability Due Diligence
Sonic Healthcare Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Sonic Healthcare Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
SHL Solvency Score
Solvency Due Diligence
Sonic Healthcare Ltd's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Sonic Healthcare Ltd's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SHL Price Targets Summary
Sonic Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for SHL is 28.18 AUD with a low forecast of 23.92 AUD and a high forecast of 33.82 AUD.
Dividends
Current shareholder yield for SHL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SHL Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. The company is headquartered in Macquarie, New South Wales and currently employs 38,000 full-time employees. The firm is engaged in the specialist operations in laboratory medicine / pathology, radiology, general practice medicine, and corporate medical services. The firm's segments include Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. Sonic Clinical Services (SCS) is the primary care division of the Company, which provides a range of health services. The firm's services are provided to medical practitioners, hospitals, community health services, and their collective patients. The firm has more than 100 radiology centers.
Contact
IPO
Employees
Officers
The intrinsic value of one SHL stock under the Base Case scenario is 31.37 AUD.
Compared to the current market price of 27.97 AUD, Sonic Healthcare Ltd is Undervalued by 11%.